Qlife Holding AB (publ) (QLIFE.ST)
- Previous Close
2.4300 - Open
2.4000 - Bid 2.1500 x --
- Ask 2.2500 x --
- Day's Range
2.1500 - 2.4000 - 52 Week Range
1.3010 - 6.2000 - Volume
33,175 - Avg. Volume
142,684 - Market Cap (intraday)
28.091M - Beta (5Y Monthly) 0.60
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Its biomarkers include CRP/C-reactive protein, procalcitonin, Nt-pro-BNP, lipids, HbA1c/D-vitami, and D-dimer. Qlife Holding AB (publ) was incorporated in 2019 and is based in Helsingborg, Sweden.
www.qlifeholding.comRecent News: QLIFE.ST
View MorePerformance Overview: QLIFE.ST
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: QLIFE.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: QLIFE.ST
View MoreValuation Measures
Market Cap
28.09M
Enterprise Value
34.08M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
98.88k
Price/Book (mrq)
--
Enterprise Value/Revenue
382.87
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-31.87%
Return on Equity (ttm)
--
Revenue (ttm)
50k
Net Income Avi to Common (ttm)
-37.43M
Diluted EPS (ttm)
-0.6100
Balance Sheet and Cash Flow
Total Cash (mrq)
2.71M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-25.42M